Skip to main content

Modern Surgical Pathology Through the Expert Eyes of APSS-USCAP

Evaluated by: 
David B. Kaminsky, MD, FIAC, October 26, 2018
Original release date: December 20, 2018
Access to this course expires on:  October 26, 2021, at 11:59 PM Pacific Time
CME 24

Course Description

This inaugural co-branded interactive microscopy course presents the synergistic union of expert surgical pathologists from the prestigious Arthur Purdy Stout Society and from USCAP, collaborating (through education of pathologists) to eliminate a variety of practice gaps in diagnostic surgical pathology. For example, there is a misdiagnosis rate of about 10% in breast biopsies, but for some notoriously problematic lesions, the rate is even higher.  

A review of the literature and the collective clinical experience of this faculty as consultant surgical pathologists have clearly documented areas in diagnostic surgical pathology that remain problematic even for experienced pathologists. Examples include the categorization of proliferative breast lesions, cervical intraepithelial neoplasia, small glandular proliferations in the prostate, and soft tissue lesions. With the frequent use of core needle biopsy, pathologists are often faced with the challenge of distinguishing these entities on small specimen samples.

The value of this course is its intent to eliminate diagnostic errors by highlighting pitfalls and approaches to resolve them using routine microscopic examination of H&E-stained sections and immuno-stains. The role of newer adjunctive molecular tests will also be discussed where appropriate. Thus, this course addresses medical knowledge and competence with the goal of improving clinical practice.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  • Evaluate diagnostic criteria and clinical significance of various common and uncommon benign, in situ and malignant lesions of the breast, GI and GYN tract, prostate, lung, head and neck and soft tissues in core needle biopsy specimens and surgical specimens 
  • Describe differential diagnostic problems commonly encountered in these sites and develop strategies to resolve them in the practice environment 
  • Eliminate diagnostic error by highlighting pitfalls and approaches to resolving them in surgical pathology using both routine microscopic examination of H&-stained sections and immuno-stains 
  • Discuss the uses and limitations of immunohistochemistry in diagnostic surgical pathology 
  • Discuss the role of newer adjunctive molecular tests where appropriate 
  • Address both medical knowledge and competence with the goal of improving clinical practice

Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the United States and Canadian Academy of Pathology and the Arthur Purdy Stout Society of Surgical Pathologists. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 24 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Beginning in 2021, the American Board of Pathology (ABPath) will no longer require Self-Assessment Modules (SAMs) for Part II Lifelong Learning of the Continuing Certification program. For additional information, visit the ABPath website.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty and planners reported relevant financial relationships: Jason L. Hornick, MD, PhD: Consultant, Eli Lilly, Epizyme; Paul VanderLaan, Consultant, Gala Therapeutics

The following faculty and planners reported no relevant financial relationships: Rhonda Yantiss, MD, Laura Collins, MD, Justin Bishop, MD, Marisa Nucci, MD, Rajiv Patel, MD, Cristina Magi-Galluzzi

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

Buy the entire Modern Surgical Pathology Through the Expert Eyes of APSS-USCAP course and get a great discount!

Not A Member? Click Here